Nicole Simone

TitleProfessor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address111 S. 11th Street
Philadelphia PA 19107
Phone215-955-6702
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Simone is an expert in using dietary alteration to increase the effectiveness of cytotoxic therapy, such as radiation and chemotherapy, in breast and prostate cancer in both the laboratory and clinic. Her research interest is to change the landscape of cancer care by empowering patients to use dietary interventions to improve outcomes. The overarching goal of the Simone laboratory, is to increase the radiation sensitivity of tumors with a poor response to standard therapies. To accomplish this, the lab uses diet to alter cell metabolism via signaling pathways to increase cancer cells’ vulnerability to cytotoxic therapy. Through the laboratory studies, new strategies for treating radiation resistant tumors, which has led to the development of innovative clinical trials.

    Dr. Simone is the Co-Leader of the Breast Cancer Research Program for the Sidney Kimmel Cancer Center and the Margaret Q. Landenberger Endowed Associate Professor in the Department of Radiation Oncology at Thomas Jefferson University. She has considerable experience in translational research, medical treatment, education and training. I joined the Jefferson faculty after a position as an Assistant Clinical Investigator at the National Cancer Institute.

    Dr. Simone’s laboratory has contributed significantly to studying regulation of microRNAs and the downstream effects of microRNAs on cell metabolism via dietary alterations. Her laboratory demonstrated for the first time that caloric restriction (CR) modifies microRNA expression (Ørom et al., Cell Cycle, 2012). The Simone laboratory then explored the physiologic impact of CR and demonstrated that CR can augment radiation therapy (Saleh et al., Cell Cycle, 2013), which she then translated directly into a clinical trial using diet during radiation for early stage breast cancer patients (NCT01819233). The lab found the same improved physiologic response of the primary tumor in vivo when CR was combined with chemotherapy, which was translated directly to a clinical trial (NCT02827370). Dr. Simone’s laboratory also investigated the role of microRNAs in the ability of CR to decrease metastatic disease burden via control of the ECM (Jin et al., Breast Cancer Res Treat, 2014; Simone et al., Cell Cycle, 2016) which is being considered as a NRG Oncology clinical trial concept. These findings led to her third IIT in which diet modulation prior to definitive oncologic surgery for patients with endometrial, prostate, and breast cancer will be evaluated to favorably alter expression of microRNAs as drivers of cancer progression (NCT02983279).

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wang JH, Deek MP, Mendes AA, Song Y, Shetty A, Bazyar S, Van der Eecken K, Chen E, Showalter TN, Royce TJ, Todorovic T, Huang HC, Houck SA, Yamashita R, Kiess AP, Song DY, Lotan T, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N, Berlin A, Onal C, Esteva A, Feng FY, Tran PT, Sutera P, Ost P. Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer. Radiother Oncol. 2024 Nov 06; 202:110618. PMID: 39510141.
      Citations:    
    2. Calderon-Aparicio A, He J, Simone NL. S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer. Int J Mol Sci. 2024 Sep 28; 25(19). PMID: 39408794.
      Citations:    
    3. Cao Y, Sutera P, Silva Mendes W, Yousefi B, Hrinivich T, Deek M, Phillips R, Song D, Kiess A, Cem Guler O, Torun N, Reyhan M, Sawant A, Marchionni L, Simone NL, Tran P, Onal C, Ren L. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics. Radiother Oncol. 2024 10; 199:110443. PMID: 39094629.
      Citations:    
    4. Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW, Simone NL, Alnahhas I, Shi W. Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM). J Clin Neurosci. 2024 Jul 27; 127:110754. PMID: 39068727.
      Citations:    
    5. Wen KY, Burke SE, Jacoby JL, Liang J, Simone NL. RE: Dietary interventions in cancer: a systematic review of all randomized controlled trials. J Natl Cancer Inst. 2024 Jun 18. PMID: 38889290.
      Citations:    
    6. Sutera P, Song Y, Shetty AC, English K, Van der Eecken K, Guler OC, Wang J, Cao Y, Bazyar S, Verbeke S, Van Dorpe J, Fonteyne V, De Laere B, Mishra M, Rana Z, Molitoris J, Ferris M, Kiess A, Song DY, DeWeese T, Pienta KJ, Barbieri C, Marchionni L, Ren L, Sawant A, Simone N, Berlin A, Onal C, Tran PT, Ost P, Deek MP. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer. Eur Urol Oncol. 2024 Jun 10. PMID: 38862340.
      Citations:    
    7. Esquea EM, Ciraku L, Young RG, Merzy J, Talarico AN, Ahmed NN, Karuppiah M, Ramesh A, Chatoff A, Crispim CV, Rashad AA, Cocklin S, Snyder NW, Beld J, Simone NL, Reginato MJ, Dick A. Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells. Front Pharmacol. 2024; 15:1394685. PMID: 38818373.
      Citations:    
    8. Lombardo J, Castillo E, Castillo R, Miller R, Jones B, Miften M, Kavanagh B, Dicker A, Boyle C, Leiby B, Banks J, Simone NL, Movsas B, Grills I, Guerrero T, Rusthoven CG, Vinogradskiy Y. Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report. Int J Radiat Oncol Biol Phys. 2024 Apr 12. PMID: 38614278.
      Citations:    
    9. Nelson NG, Burke SE, Cappelli L, Matlack LE, Smith AP, Francois N, Lombardo JF, Shah YB, Wen KY, Shafi AA, Simone NL. Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles. Clocks Sleep. 2024 Mar 21; 6(1):200-210. PMID: 38534802.
      Citations:    
    10. Choi W, Jia Y, Kwak J, Werner-Wasik M, Dicker AP, Simone NL, Storozynsky E, Jain V, Vinogradskiy Y. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clin Cancer Inform. 2024 Mar; 8:e2300241. PMID: 38452302.
      Citations:    
    11. Zhao L, Wang Y, Sun X, Zhang X, Simone N, He J. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Int J Mol Sci. 2024 Feb 17; 25(4). PMID: 38397056.
      Citations:    
    12. Nelson NG, Lombardo JF, Shimada A, Ruggiero ML, Smith AP, Ko K, Leader AE, Mitchell EP, Simone NL. Physician Perceptions on Cancer Screening for LGBTQ+ Patients. Cancers (Basel). 2023 Jun 01; 15(11). PMID: 37296978.
      Citations:    
    13. McIntire RK, Juon HS, Keith SW, Simone NL, Waters D, Lewis E, Zeigler-Johnson C. A novel method for measuring the burden of breast cancer in neighborhoods. Prev Med Rep. 2023 Jun; 33:102218. PMID: 37223584.
      Citations:    
    14. Butryn ML, Hagerman CJ, Crane NT, Ehmann MM, Forman EM, Milliron BJ, Simone NL. A Proof-of-Concept Pilot Test of a Behavioral Intervention to Improve Adherence to Dietary Recommendations for Cancer Prevention. Cancer Control. 2023 Jan-Dec; 30:10732748231214122. PMID: 37950612.
      Citations:    
    15. Lombardo J, Schmucker AM, Keith SW, Ronghe A, Smith A, Ali AS, Niazi M, Denton M, Swartz K, Chapman A, Simone NL. Markers and associations of nutrition identified in a senior adult oncology clinic. J Geriatr Oncol. 2022 Oct 14. PMID: 36253248.
      Citations:    
    16. Horgan OZ, Crane NT, Forman EM, Milliron BJ, Simone NL, Zhang F, Butryn ML. Optimizing an mHealth Intervention to Change Food Purchasing Behaviors for Cancer Prevention: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2022 Jun 24; 11(6):e39669. PMID: 35749216.
      Citations:    
    17. Squeo GC, Lattimore CM, Simone NL, Suralik G, Dutta SW, Schad MD, Su L, Libby B, Janowski EM, Showalter SL, Lobo JM, Showalter TN. A comparative study using time-driven activity-based costing in single-fraction breast high-dose rate brachytherapy: An integrated brachytherapy suite vs. decentralized workflow. Brachytherapy. 2022 Feb 03. PMID: 35125328.
      Citations:    
    18. Nelson N, Lombardo J, Matlack L, Smith A, Hines K, Shi W, Simone NL. Chronoradiobiology of Breast Cancer: The Time Is Now to Link Circadian Rhythm and Radiation Biology. Int J Mol Sci. 2022 Jan 25; 23(3). PMID: 35163264.
      Citations:    
    19. Maisel BA, Yi M, Peck AR, Sun Y, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Nevalainen MT, Tanaka T, Simone N, Wang LL, Rui H, Chervoneva I. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. Cancers (Basel). 2022 Jan 08; 14(2). PMID: 35053472.
      Citations:    
    20. Lombardo J, Ko K, Shimada A, Nelson N, Wright C, Chen J, Maity A, Ruggiero ML, Richard S, Papanagnou D, Mitchell E, Leader A, Simone NL. Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity. Cancer Causes Control. 2022 Apr; 33(4):559-582. PMID: 34984592.
      Citations:    
    21. Shastri AA, Lombardo J, Okere SC, Higgins S, Smith BC, DeAngelis T, Palagani A, Hines K, Monti DA, Volpe S, Mitchell EP, Simone NL. Personalized Nutrition as a Key Contributor to Improving Radiation Response in Breast Cancer. Int J Mol Sci. 2021 Dec 24; 23(1). PMID: 35008602.
      Citations:    
    22. Miller RC, Simone BA, Lombardo JF, Taylor J, Nowak-Choi K, Ko K, Ferguson L, Donnelly A, Ali AS, Shi W, Dicker AP, Simone NL. A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual. Telemed Rep. 2021; 2(1):171-178. PMID: 34250522.
      Citations:    
    23. Manukian G, Kivolowitz C, DeAngelis T, Shastri AA, Savage JE, Camphausen K, Rodeck U, Zarif JC, Simone NL. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells. Int J Radiat Oncol Biol Phys. 2021 Feb 26. PMID: 33647370.
      Citations:    
    24. Dan T, Shastri AA, Palagani A, Buraschi S, Neill T, Savage JE, Kapoor A, DeAngelis T, Addya S, Camphausen K, Iozzo RV, Simone NL. miR-21 Plays a Dual Role in Tumor Formation and Cytotoxic Response in Breast Tumors. Cancers (Basel). 2021 Feb 20; 13(4). PMID: 33672628.
      Citations:    
    25. Taylor JM, Song A, Nowak K, Dan T, Simone B, Harrison A, Doyle L, Lockamy V, Anne P, Simone N. Dosimetric Comparisons of Simulation Techniques for Left-Sided Breast Cancer in the COVID-19 Era: Techniques to Reduce Viral Transmission and Respect the Therapeutic Ratio. Cureus. 2021 Feb 15; 13(2):e13354. PMID: 33747655.
      Citations:    
    26. Zaorsky NG, Allenby T, Lin J, Rosenberg J, Simone NL, Schmitz KH. TEMPORARY REMOVAL: Exercise therapy and radiation therapy (EXERT) for cancer: a systematic review. Int J Radiat Oncol Biol Phys. 2020 Nov 19. PMID: 33220396.
      Citations:    
    27. Allenby TH, Crenshaw ML, Mathis K, Champ CE, Simone NL, Schmitz KH, Tchelebi LT, Zaorsky NG. A systematic review of home-based dietary interventions during radiation therapy for cancer. Tech Innov Patient Support Radiat Oncol. 2020 Dec; 16:10-16. PMID: 32995577.
      Citations:    
    28. Wright CM, Shastri AA, Bongiorno E, Palagani A, Rodeck U, Simone NL. Is Host Metabolism the Missing Link to Improving Cancer Outcomes? Cancers (Basel). 2020 Aug 19; 12(9). PMID: 32825010.
      Citations:    
    29. Meneveau MO, Petroni GR, Varhegyi NE, Hulse JC, Schroen AT, Brenin DR, Janowski EM, Berger AC, Lazar MA, Simone NL, Showalter TN, Showalter SL. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy. 2020 Jun 19. PMID: 32571746.
      Citations:    
    30. Lombardo J, Simone N. Care of Transgender Persons. N Engl J Med. 2020 04 09; 382(15):1481. PMID: 32268037.
      Citations:    
    31. Song A, Manukian G, Taylor A, Anne PR, Simone NL. Concerns for activated breathing control (ABC) with breast cancer in the era of COVID-19: Maximizing infection control while minimizing heart dose. Adv Radiat Oncol. 2020 Apr 01. PMID: 32292838.
      Citations:    
    32. Shastri AA, Saleh A, Savage JE, DeAngelis T, Camphausen K, Simone NL. Dietary alterations modulate the microRNA 29/30 and IGF-1/AKT signaling axis in breast Cancer liver metastasis. Nutr Metab (Lond). 2020; 17:23. PMID: 32211051.
      Citations:    
    33. Puccetti MV, Adams CM, Dan TD, Palagani A, Simone BA, DeAngelis T, Eischen CM, Simone NL. miR-21 is required for hematopoietic cell viability following radiation exposure. Int J Radiat Oncol Biol Phys. 2019 Apr 27. PMID: 31039423.
      Citations:    
    34. Scott DA, Casadonte R, Cardinali B, Spruill L, Mehta AS, Carli F, Simone N, Kriegsmann M, Del Mastro L, Kriegsmann J, Drake RR. Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues. Proteomics Clin Appl. 2019 01; 13(1):e1800014. PMID: 30592377.
      Citations:    
    35. Simone BA, Ko K, Simone NL. Re: Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases. Breast Cancer Res Treat. 2018 Nov; 172(2):511. PMID: 30259336.
      Citations:    
    36. McCall NS, Simone BA, Mehta M, Zhan T, Ko K, Nowak-Choi K, Rese A, Venkataraman C, Andrews DW, Anne' PR, Dicker AP, Shi W, Simone NL. Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer. Breast Cancer Res Treat. 2018 Nov; 172(1):221-230. PMID: 30022328.
      Citations:    
    37. Simone BA, Palagani A, Strickland K, Ko K, Jin L, Lim MK, Dan TD, Sarich M, Monti DA, Cristofanilli M, Simone NL. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model. Cell Cycle. 2018 Jun 18. PMID: 29912618.
      Citations:    
    38. Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug 01; 98(5):1028-1035. PMID: 28721885.
      Citations:    
    39. Toss A, Palazzo J, Berger A, Guiles F, Sendecki JA, Simone N, Anne R, Avery T, Jaslow R, Lazar M, Tsangaris T, Cristofanilli M. Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less. Breast. 2016 Oct; 29:223-30. PMID: 27506636.
      Citations:    
    40. Wright C, Simone NL. Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr Opin Clin Nutr Metab Care. 2016 Jul; 19(4):294-9. PMID: 27168354.
      Citations:    
    41. Simone BA, Dan T, Palagani A, Jin L, Han SY, Wright C, Savage JE, Gitman R, Lim MK, Palazzo J, Mehta MP, Simone NL. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer. Cell Cycle. 2016 Sep; 15(17):2265-74. PMID: 27027731.
      Citations:    
    42. Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. J Neurooncol. 2016 May; 127(3):535-9. PMID: 26821711.
      Citations:    
    43. Kim H, Malatesta TM, Simone NL, Den RB, McAna J, Dicker AP, Bar Ad V. A single activity with a practice quality improvement project for faculty and a quality improvement project for residents. Pract Radiat Oncol. 2016 Mar-Apr; 6(2):114-8. PMID: 26723550.
      Citations:    
    44. Dan TD, Simone NL. Not so fast: dietary restriction improves chemotherapy-related toxicity. Cell Cycle. 2015 Aug 18; 14(16):2554-5. PMID: 26102577.
      Citations:    
    45. Eldredge-Hindy HB, Duffy D, Yamoah K, Simone NL, Skowronski J, Dicker AP, Anne PR. Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold. Pract Radiat Oncol. 2015 May-Jun; 5(3):162-8. PMID: 25957186.
      Citations:    
    46. Eldredge-Hindy H, Lockamy V, Crawford A, Nettleton V, Werner-Wasik M, Siglin J, Simone NL, Sidhu K, Anne PR. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial. Pract Radiat Oncol. 2015 Jan-Feb; 5(1):4-10. PMID: 25567159.
      Citations:    
    47. Dan TD, Wright CM, Simone NL. What benefits could caloric restriction bring to cancer patients? Future Oncol. 2014 Dec; 10(16):2543-6. PMID: 25531042.
      Citations:    
    48. Eldredge-Hindy HB, Rosenberg AL, Simone NL. Intraoperative radiotherapy for breast cancer: the lasting effects of a fleeting treatment. Int J Breast Cancer. 2014; 2014:214325. PMID: 25180098.
      Citations:    
    49. Simone BA, Ly D, Savage JE, Hewitt SM, Dan TD, Ylaya K, Shankavaram U, Lim M, Jin L, Camphausen K, Mitchell JB, Simone NL. microRNA Alterations Driving Acute and Late Stages of Radiation-Induced Fibrosis in a Murine Skin Model. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90(1):44-52. PMID: 24986745.
      Citations:    
    50. Wright CM, Dan T, Dicker AP, Simone NL. microRNAs: The Short Link between Cancer and RT-Induced DNA Damage Response. Front Oncol. 2014; 4:133. PMID: 24926436.
      Citations:    
    51. Jin L, Lim M, Zhao S, Sano Y, Simone BA, Savage JE, Wickstrom E, Camphausen K, Pestell RG, Simone NL. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster. Breast Cancer Res Treat. 2014 Jul; 146(1):41-50. PMID: 24863696.
      Citations:    
    52. Palmer JD, Soule BP, Simone BA, Zaorsky NG, Jin L, Simone NL. MicroRNA expression altered by diet: can food be medicinal? Ageing Res Rev. 2014 Sep; 17:16-24. PMID: 24833329.
      Citations:    
    53. Simone BA, Champ CE, Rosenberg AL, Berger AC, Monti DA, Dicker AP, Simone NL. Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncol. 2013 Jul; 9(7):959-76. PMID: 23837760.
      Citations:    
    54. Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG, Mitchell JB, Lisanti MP, Simone NL. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle. 2013 Jun 15; 12(12):1955-63. PMID: 23708519.
      Citations:    
    55. Champ CE, Mishra MV, Showalter TN, Ohri N, Dicker AP, Simone NL. Dietary recommendations during and after cancer treatment: consistently inconsistent? Nutr Cancer. 2013 Apr; 65(3):430-9. PMID: 23530643.
      Citations:    
    56. Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG, Dicker AP, Simone NL. Nutrient restriction and radiation therapy for cancer treatment: when less is more. Oncologist. 2013; 18(1):97-103. PMID: 23299773.
      Citations:    
    57. Champ CE, Simone NL. In reply. Oncologist. 2013; 18(9):1057. PMID: 24062423.
      Citations:    
    58. Siglin J, Champ CE, Vakhnenko Y, Anne PR, Simone NL. Radiation therapy for locally recurrent breast cancer. Int J Breast Cancer. 2012; 2012:571946. PMID: 23091733.
      Citations:    
    59. Champ CE, Volek JS, Siglin J, Jin L, Simone NL. Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? Int J Breast Cancer. 2012; 2012:506868. PMID: 23050155.
      Citations:    
    60. Ørom UA, Lim MK, Savage JE, Jin L, Saleh AD, Lisanti MP, Simone NL. MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle. 2012 Apr 1; 11(7):1291-5. PMID: 22421148.
      Citations:    
    61. Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, Lippman ME, Glatstein E, Swain SM, Danforth DN, Camphausen K. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Treat. 2012 Feb; 132(1):197-203. PMID: 22113254.
      Citations:    
    62. Saleh AD, Savage JE, Cao L, Soule BP, Ly D, DeGraff W, Harris CC, Mitchell JB, Simone NL. Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One. 2011; 6(10):e24429. PMID: 22022355.
      Citations:    
    63. Simone CB, Lonser RR, Ondos J, Oldfield EH, Camphausen K, Simone NL. Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol. 2011 Sep; 13(9):1030-6. PMID: 21798886.
      Citations:    
    64. Argiris A, Duffy AG, Kummar S, Simone NL, Arai Y, Kim SW, Rudy SF, Kannabiran VR, Yang X, Jang M, Chen Z, Suksta N, Cooley-Zgela T, Ramanand SG, Ahsan A, Nyati MK, Wright JJ, Van Waes C. Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. Clin Cancer Res. 2011 Sep 1; 17(17):5755-64. PMID: 21750205.
      Citations:    
    65. Simone CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol. 2011 Dec; 101(3):376-82. PMID: 21663988.
      Citations:    
    66. Soule BP, Simone NL, DeGraff WG, Choudhuri R, Cook JA, Mitchell JB. Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol. 2010; 5:8. PMID: 20128919.
      Citations:    
    67. Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, Harris CC, Gius D, Mitchell JB. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One. 2009; 4(7):e6377. PMID: 19633716.
      Citations:    
    68. Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol. 2008 Dec; 180(6):2447-51; discussion 2451-2. PMID: 18930498.
      Citations:    
    69. Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB. Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal. 2007 Oct; 9(10):1731-43. PMID: 17665971.
      Citations:    
    70. Simone NL, Ménard C, Soule BP, Albert PS, Guion P, Smith S, Godette D, Crouse NS, Sciuto LC, Cooley-Zgela T, Camphausen K, Coleman CN, Singh AK. Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys. 2008 Jan 1; 70(1):90-5. PMID: 17855015.
      Citations:    
    71. Soule BP, Brown JM, Kushnir-Sukhov NM, Simone NL, Mitchell JB, Metcalfe DD. Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol. 2007 Sep 1; 179(5):3276-86. PMID: 17709544.
      Citations:    
    72. Simone NL, Soule BP, Gerber L, Augustine E, Smith S, Altemus RM, Mitchell JB, Camphausen KA. Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study. Radiat Oncol. 2007; 2:19. PMID: 17540023.
      Citations:    
    73. Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB. The chemistry and biology of nitroxide compounds. Free Radic Biol Med. 2007 Jun 1; 42(11):1632-50. PMID: 17462532.
      Citations:    
    74. Singh AK, Ménard C, Guion P, Simone NL, Smith S, Crouse NS, Godette DJ, Cooley-Zgela T, Sciuto LC, Coleman J, Pinto P, Albert PS, Camphausen K, Coleman CN. Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1008-13. PMID: 16730138.
      Citations:    
    Simone's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (165)
    Explore
    _
    Co-Authors (59)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _